Browse > Article
http://dx.doi.org/10.15205/kschs.2014.2.2.133

Role of Radiation Therapy in Oncologic Emergencies  

Lee, Jun-Ho (Department of Emergency Medical Technology, Daejeon University)
Baek, Hong-Seok (Department of Emergency Medical Technology, Daejeon University)
Park, Sang-Sub (Department of Emergency Medical Technology, Chungcheong University)
Park, Hyun-Suk (Department of Health Service Management, Daejeon University)
Lee, Seok-Ho (Department of Radiation Oncology, Gachon University Gil Medical Center)
Publication Information
Journal of Korean Clinical Health Science / v.2, no.2, 2014 , pp. 133-147 More about this Journal
Abstract
Purpose. Radiation therapy for oncologic emergencies is an important modality in the management of cancer patients. The aim of the present study was to review the roles of RT in oncologic emergencies based on literature review. Methods. The oncologic emergencies requiring rapid treatment include superior vena cava syndrome, spinal cord compression, brain metastasis, and bone metastasis. We reviewed the literatures on the pathophysiology, diagnosis, and treatment of oncologic emergencies. Results. In this literature review, radiation therapy among treatment modalities for oncologic emergencies has been shown to be fast and very effective treatment modality for oncologic emergencies. Conclusions. Based on this review, we conclude that the literature provides support for the role of radiation therapy in the situation of oncologic emergencies. As the number of cancer patients increase, the prevalence of oncologic emergencies will increase. In the future, the development of RT techniques will provide the improvement of not only patient's quality of life but also the survival.
Keywords
Emergency; Oncology; Palliation; Radiation therapy;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Wan JF, Bezjak A. Superior vena cava syndrome. Hematol Oncol Clin North Am 2010;24:501-513.   DOI
2 Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2006;85:37-42.   DOI
3 Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev 2001;CD001316.
4 Kvale PA, Selecky PA, Prakash UB. Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:368S-403S.   DOI
5 Ostler PJ, Clarke DP, Watkinson AF, et al. Superior vena cava obstruction: a modern management strategy. Clin Oncol (R Coll Radiol) 1997;9:83-89.   DOI   ScienceOn
6 Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol 2005;53:373-388;quiz 389-392   DOI   ScienceOn
7 Wan JF, Bezjak A. Superior vena cava syndrome. Emerg Med Clin North Am 2009;27:243-255.   DOI   ScienceOn
8 Slawson RG, Scott RM. Radiation therapy in bronchogenic carcinoma. Radiology 1979;132:175-176.   DOI
9 Davenport D, Ferree C, Blake D, et al. Response of superior vena cava syndrome to radiation therapy.Cancer 1976;38:1577-1580.   DOI
10 Halfdanarson TR, Hogan WJ, Moynihan TJ. Oncologic emergencies: diagnosis and treatment. Mayo Clin Proc 2006;81:835-848.   DOI
11 Cervantes A, Chirivella I. Oncological emergencies. Ann Oncol 2004;15 Suppl 4:iv299-306.   DOI
12 Cavanna L, Berte R, Bidin L, et al. Oncologic emergencies secondary to advanced colorectal cancer successfully treated with oxaliplatin/5-fluorouracil/leucovorin: report of three cases. J Chemother 2005;17:334-338.   DOI
13 Schiff D. Spinal cord compression. Neurol Clin 2003;21:67-86, viii.   DOI
14 SchoutenLJ, Rutten J, Huveneers HA, et al. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002;94:2698-2705.   DOI   ScienceOn
15 Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005;366:643-648.   DOI   ScienceOn
16 Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005;75:5-14.   DOI   ScienceOn
17 Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004;22:2865-2872.   DOI   ScienceOn
18 Delattre JY, Krol G, Thaler HT, et al. Distribution of brain metastases. Arch Neurol 1988;45:741-744.   DOI   ScienceOn
19 Tsao MN, Lloyd NS, Wong RK, et al. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 2005;31:256-273.   DOI
20 Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998;280:1485-1489.
21 Gaspar LE, Mehta MP, Patchell RA, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96:17-32.   DOI   ScienceOn
22 Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management ofpatients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96:45-68.   DOI
23 Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-751.   DOI   ScienceOn
24 Mintz A, Perry J, Spithoff K, et al. Management of single brain metastasis: a practice guideline. Curr Oncol 2007;14:131-143.   DOI   ScienceOn
25 Mehta MP, Tsao MN, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005;63:37-46.   DOI   ScienceOn
26 Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;12:6243s-6249s.   DOI   ScienceOn
27 Nielsen OS, Munro AJ, Tannock IF. Bone metastases: pathophysiology and management policy. J Clin Oncol 1991;9: 509-524.   DOI
28 Wu JS, Wong RK, Lloyd NS, et al. Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases - an evidence-based practice guideline. BMC Cancer 2004;4:71.   DOI
29 Roos DE, Turner SL,O'Brien PC, et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005;75:54-63.   DOI
30 Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011;103:117-128.   DOI   ScienceOn
31 Schiff D, O'Neill BP, Suman VJ. Spinal .epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach. Neurology 1997;49:452-456.   DOI   ScienceOn
32 Stehbens WE. History of aneurysms. Med Hist 1958;2:274-280.   DOI
33 Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med 2007;356:1862-1869.   DOI   ScienceOn
34 Rades D, Stalpers LJ, Veninga T, et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005;23:3366-3375.   DOI   ScienceOn
35 Kalayci M, Cagavi F, Gul S, et al. Intramedullary spinal cord metastases: diagnosis and treatment - an illustrated review. Acta Neurochir (Wien) 2004;146:1347-1354.   DOI   ScienceOn
36 Boogerd W, Hart AA, van der Sande JJ, et al. Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 1991;67:1685-1695.   DOI
37 Markesbery WR, Brooks WH, Gupta GD, et al. Treatment for patients with cerebral metastases. Arch Neurol 1978;35:754-756.   DOI   ScienceOn
38 Egawa S, Tukiyama I, Akine Y, et al. Radiotherapy of brain metastases. Int J Radiat Oncol Biol Phys 1986;12:1621-1625.   DOI
39 Horton J, Baxter DH, Olson KB. The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med 1971;111:334-336.   DOI
40 Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295:2483-2491.   DOI   ScienceOn
41 Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363:1665-1672.   DOI   ScienceOn
42 Goitein M, Abrams M, Rowell D, et al. Multi-dimensional treatment planning: II. Beam's eye-view, back projection, and projection through CT sections. Int J Radiat Oncol Biol Phys 1983;9:789-797.   DOI   ScienceOn
43 Mohan R, Wu Q, Wang X, et al. Intensity modulation optimization, lateral transport of radiation, and margins. Med Phys 1996;23:2011-2021.   DOI
44 Lee SH, Lee KC, Choi J, et al. Clinical application of RapidArc volumetric modulated arc therapy as a component in whole brain radiation therapy for poor prognostic, four or more multiple brain metastases. Radiat Oncol J 2012;30:53-61.   과학기술학회마을   DOI   ScienceOn
45 Lutz S, Lo SS, Chow E, et al. Radiotherapy for metastatic bone disease: current standards and future prospectus. Expert Rev Anticancer Ther 2010;10:683-695.   DOI
46 Fong Y, Fortner J, Sun RL,et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230: 309-318;discussion 318-321.   DOI   ScienceOn
47 Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol 2008;7:459-466.   DOI   ScienceOn